Tentative Program (November 04)
Click here to download program in pdf-format
Wednesday 2nd of December
10.00 Registration
Posters are handed in and mounted by us
13.00 Lunch
Opening
14.00 Opening by Anne-Grete Strøm-Erichsen, the Norwegian Minister of Health
Welcome by Ola Myklebost
Oslo Cancer Cluster Keynote Lecture
Chair: Ola Myklebost
14.10 Pier Giuseppe Pelicci, Milan, Italy
Biological Properties of Cancer Stem Cells
Session I: Stemcellness in tumours I
Chair: Rolf Bjerkevig
15.00 Christopher Heeschen, Madrid, Spain
Pancreatic Cancer Stem Cells – Insights and Perspectives
15.30 Christiane Bruns, Munich, Germany
Cancer stem cells - target for cancer therapy?
16.00 Coffee
Session II: Stemcellness in tumours II
Chair: Steinar Aamdal
16.30 César Cobaleda, Madrid, Spain
The role of cellular plasticity in oncogenic reprogramming
17.00 Ron McKay, Bethesda, USA
Cell interactions that control stem cells in mammals
18.30 Bus to new Institute for Cancer Research Building
EACR Keynote lecture
19.00 Welcome by Erik Boye,
Hydro’s Fund and Institute for Cancer Research
Introduction by Anne-Lise Børresen-Dale, President of EACR
19.15 Hans Clevers, Utrecht, The Netherlands
Lgr5 Intestinal Stem Cells in self-renewal and cancer
20.00 - 22.00 Tapas, posters and mingling.
22.00 Bus back to hotel
Thursday 3rd of December
Cancer Society Keynote Lecture
Supported by a grant from Dentist Aase and Wife’s Donation
Chair: Jannikke Ludt, The Norwegian Cancer Society
09.00 William Matsui, Baltimore, USA
The clinical translation of cancer stem cells in B cell malignancies
Session III: Applying stem cell knowledge in today’s treatment
Chair: Gustav Gaudernack
10.00 Hugues de Thé, Paris, France
LIC clearance by treatment-induced oncogene degradation
10.30 Andreas Trumpp, Heidelberg, Germany
Dormancy in Stem Cells
11.00-11.30 Coffee
Session IV: Stem cell programs in cancer
Chair: Stefan Krauss
11.30 Eduard Batlle, Barcelona, Spain
Intestinal stem cell genes in colorectal cancer
12.00 Mahendra Rao, San Diego, USA
Neural stem cells and cancer
12.30 Eric Chi Wai So, London, UK
Dissecting the Molecular Pathways Mediating Self-Renewal of Leukemic Stem Cells
13.00 Poster prize by Bjarte Reve, OCC
1300 - 1400 Lunch
Session V: Stem cell signalling in tumours
Chair: Harald Stenmark
14.15 Ariel Ruiz i Altaba, Geneva, Switzerland
Hedgehog-GLI1 signalling is essential in epithelial tumour cells and drives cancer stem cell expansion
14.45 Rune Toftgard, Stockholm, Sweden
Hedgehog signalling in skin cancer and tissue stem cells
15.15 Urban Lendahl, Stockholm, Sweden
Notch signalling in stem cells and cancer
15.45-16.15 Coffee
Session VI: Stem-like cells in breast cancer
Chair: Gunhild Mælandsmo
16.15 Marc LaBarge, Berkeley, USA
The role of the microenvironment in organizing and maintaining lineage-specific domains in mammary gland
16.45 John Stingl, Cambridge, UK
Mammary stem and progenitor cells: Understanding the cellular context of breast tumours
17.15 Ole W. Petersen, Copenhagen, Denmark
Routes to breast cancer heterogeneity: Prospective cloning of functionally distinct subpopulations by use of markers from a normal human breast lineage hierarchy
18.15 Buses to the City Hall (Rådhuset)
19.00 Reception by the Mayor of Oslo at the Town hall
Drinks & light snacks
_____
Dinner for speakers / Free evening for participants
Friday 4th of December
Session VII: Determination of cell fate
Chair: Philippe Collas
09.00 Amanda Fisher, London, UK
Stem Cells and Epigenetic Reprogramming
09.30 Tracy-Ann Read, Durham, USA
Cancer Stem Cells Reflect the Origin of Pediatric Brain Tumours
10.00 Maarten van Lohuizen, Amsterdam, The Netherlands
Role of Polycomb repressors in stem cells, cancer and development
10.30 Peter Dirks, Toronto, Canada
Self renewal and lineage commitment in brain tumour stem cells
11.00 – 11.30 Coffee
Session VIII: Lessons from embryonic systems
Chair: Ragnhild Lothe
11.30 Ralph A. Neumüller, Vienna, Austria
Controlling the balance between self-renewal and differentiation in Drosophila neural stem cells
12.00 Monica Gotta, Geneva, Switzerland
Asymmetric division in C. elegans
EMBO Young Investigator Lecture
12.30 Peter Andrews, Sheffield, UK
Human Embryonic Stem Cells: Commitment, Adaptation and Cancer
13.00 – 14.00 Lunch
Session IX: Epithelial-mesenchymal transition
Chair Ola Myklebost
14.15 Thomas Brabletz, Freiburg, Germany
Tumour invasion and metastasis: EMT and cancer stem cells
14.45 Sendurai Mani, Houston, USA
Generation of Stem-Like Cells via EMT: A New Twist in Tumour Initiation and Progression
15.15 Christina Scheel, Cambridge, USA
Formation and Maintenance of Stem Cell Traits induced by EMT
15.45 Closing remarks
16.00 End
